1-20 of 80 results for subject:GlaxoSmithKline
Librarians' tools
- Search time
- 0.263 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:GlaxoSmithKline
- We searched for
- subject_t:GlaxoSmithKline OR subject_t:"Glaxo SmithKline" OR subject_ses:36602
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
A decade ago, GlaxoSmithKline announced a £350 million investment in my constituency, which would have led to 1,000 jobs. In 2017, it reneged on that, and a few weeks ago it announced that it is closing its business altogether. We have gone from the very real prospect of having 1,000 high-paying, high-skilled pharma jobs in my constituency to the risk of having none by 2025. Will my right hon. Friend agree to meet me and throw the weight of the Government behind efforts to ensure that GSK does the right thing by my constituents and delivers for some very worried people?
A decade ago, GlaxoSmithKline announced a £350 million investment in my constituency, which would have led to 1,000 jobs. In 2017, it reneged on that, and a few weeks ago it announced that it is closing its business altogether. We have gone from the very real prospect of having 1,000 high-paying, high-skilled pharma jobs in my constituency to the risk of having none by 2025. Will my right hon. Friend agree to meet me and throw the weight of the Government behind efforts to ensure that GSK does the right thing by my constituents and delivers for some very worried people?
I thank my hon. Friend very much, and I express my deepest sympathy to all those in Ulverston affected by these job losses. I will certainly meet him. I believe that bioscience is one of the great growth areas for this country in the future, and I am determined that Barrow and Furness should take part in that boom along with everywhere else, as well as other high technologies.
I thank my hon. Friend very much, and I express my deepest sympathy to all those in Ulverston affected by these job losses. I will certainly meet him. I believe that bioscience is one of the great growth areas for this country in the future, and I am determined that Barrow and Furness should take part in that boom along with everywhere else, as well as other high technologies.
I thank my hon. Friend very much, and I express my deepest sympathy to all those in Ulverston affected by these job losses. I will certainly meet him. I believe that bioscience is one of the great growth areas for this country in the future, and I am determined that Barrow and Furness should take part in that boom along with everywhere else, as well as other high technologies.
A decade ago, GlaxoSmithKline announced a £350 million investment in my constituency, which would have led to 1,000 jobs. In 2017, it reneged on that, and a few weeks ago it announced that it is closing its business altogether. We have gone from the very real prospect of having 1,000 high-paying, high-skilled pharma jobs in my constituency to the risk of having none by 2025. Will my right hon. Friend agree to meet me and throw the weight of the Government behind efforts to ensure that GSK does the right thing by my constituents and delivers for some very worried people?
To ask the Attorney General, whether there is a point of contact for members of the public who wish to help the Serious Fraud Office investigation into GlaxoSmithKline.
To ask the Attorney General, whether there is a point of contact for members of the public who wish to help the Serious Fraud Office investigation into GlaxoSmithKline.
The Serious Fraud Office (SFO) has a secure reporting mechanism, SFO Confidential, which can be accessed through its website.
To ask the Secretary of State for Health, what steps he is taking with officials of his Department to expedite negotiations with GlaxoSmithKline on the meningitis B vaccine.
To ask the Secretary of State for Health, what steps he is taking with officials of his Department to expedite negotiations with GlaxoSmithKline on the meningitis B vaccine.
We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.
The Department has had a number of meetings with the manufacturer and is continuing to meet.
To ask the Secretary of State for Health, pursuant to the Answer of 11 March 2015 to Question 226346, when he expects negotiations with GlaxoSmithKline on the meningitis B vaccine to be concluded.
To ask the Secretary of State for Health, pursuant to the Answer of 11 March 2015 to Question 226346, when he expects negotiations with GlaxoSmithKline on the meningitis B vaccine to be concluded.
We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.
The Department has had a number of meetings with the manufacturer and is continuing to meet.
To ask the Attorney-General what the terms of reference are for the investigation by the Serious Fraud Office (SFO) into GlaxoSmithKline (GSK); whether the SFO will investigate (a) GSK's activities within the UK, (b) allegations of bribery of UK doctors, (c) promotion of Seroxat prescribing for children and (d) the...
To ask the Attorney-General what the terms of reference are for the investigation by the Serious Fraud Office (SFO) into GlaxoSmithKline (GSK); whether the SFO will investigate (a) GSK's activities within the UK, (b) allegations of bribery of UK doctors, (c) promotion of Seroxat prescribing for children and (d) the...
The Director of the Serious Fraud Office (SFO) recently announced that he has opened a criminal investigation into the commercial practices of GlaxoSmithKline plc and its subsidiaries. The SFO investigation will follow the evidence and it is not appropriate to comment while inquiries are continuing.
A press release regarding GlaxoSmithKline and information on how to contact the SFO can be found on its website at:
www.sfo.gov.uk
To ask Her Majesty’s Government, for each of the last three years for which figures are available, what was the total National Health Service expenditure on drugs and medicines produced by (1) AstraZeneca, (2) Pfizer, and (3) GlaxoSmithKline; and what percentage of the National Health Service’s total expenditure on drugs...
To ask Her Majesty’s Government, for each of the last three years for which figures are available, what was the total National Health Service expenditure on drugs and medicines produced by (1) AstraZeneca, (2) Pfizer, and (3) GlaxoSmithKline; and what percentage of the National Health Service’s total expenditure on drugs...
The following table sets out for 2011, 2012 and 2013, National Health Service spend on medicines and percentage of spend, for AstraZeneca, Pfizer and GlaxoSmithKline in primary care only.
This does not include data on NHS use of medicines in hospitals, as comparable current data sources do not take account of the discounts available.
| Net
ingredient cost and proportion of all primary care spend by
manufacturer, in England, for the years 2011, 2012 and 2013, based on
prescription items dispensed in the community in
England.1 | ||||||
| 2011 | 2012 | 2013 | ||||
| Manufacturer
name | Net
Ingredient Cost
(£000s) | Percentage
of all Primary
Care | Net
Ingredient Cost
(£000s) | Percentage
of all Primary
Care | Net
Ingredient Cost
(£000s) | Percentage
of all Primary
Care |
| AstraZeneca | 451,931 | 5.5 | 366,037 | 4.7 | 353,981 | 4.5 |
| Pfizer | 771,631 | 9.5 | 521,610 | 6.7 | 408,643 | 5.2 |
| GlaxoSmithKline | 597,634 | 7.3 | 565,881 | 7.2 | 542,992 | 6.9 |
| Total
(all primary care expenditure on medicines in
England2) | 8,164,364 | 100.0 | 7,840,390 | 100.0 | 7,888,304 | 100.0 |
Source:
Prescription Cost Analysis provided by the Health and Social Care Information Centre
Notes:1.
This may not include spend on those medicines made by the companies that are also available generically.2.
This total relates to all medicines contained within British National Formulary (BNF) Chapters 1 to 19. The cost of dressings and appliances contained within BNF Chapters 20 to 23 has been excluded.
I. Summary of product characteristics for Cervarix. 22 p. II. Summary of product characteristics for Gardasil. 23 p.
I. Summary of product characteristics for Cervarix. 22 p. II. Summary of product characteristics for Gardasil. 23 p.
To ask Her Majesty’s Government, in light of the announcement by GlaxoSmithKline of a £500 million investment programme in the UnitedKingdom and the statement by the Chancellor of the Exchequer in his written forecast that this was a result of the Government’s proposal to reduce the corporate tax rate on...
To ask Her Majesty’s Government, in light of the announcement by GlaxoSmithKline of a £500 million investment programme in the UnitedKingdom and the statement by the Chancellor of the Exchequer in his written forecast that this was a result of the Government’s proposal to reduce the corporate tax rate on...
Lords statement on the Office for Budget Responsibility's first Autumn Forecast (Cm 7979).
Lords statement on the Office for Budget Responsibility's first Autumn Forecast (Cm 7979).
I am very grateful to my noble friend. I can confirm the figures that he quoted. The relevance is that, for all the rebalancing of the economy that we are doing and the very significant rebalancing of the welfare system, the shift of jobs out of the public sector is...
I am very grateful to my noble friend. I can confirm the figures that he quoted. The relevance is that, for all the rebalancing of the economy that we are doing and the very significant rebalancing of the welfare system, the shift of jobs out of the public sector is...
Will my noble friend not allow the noble Lord, Lord Eatwell, to get away with the idea that this year is Labour’s year? The fundamental change is that we have confidence; under them, we would not have had confidence. We would not have been able to pay our bills and...
Will my noble friend not allow the noble Lord, Lord Eatwell, to get away with the idea that this year is Labour’s year? The fundamental change is that we have confidence; under them, we would not have had confidence. We would not have been able to pay our bills and...
I am grateful to my noble friend for pointing out the changed direction of travel since the new Government came in. I do not want to wade into a Cambridge argument. As a mere Oxford man, I always found my economics professors rather more cheery in their outlook, but perhaps...
I am grateful to my noble friend for pointing out the changed direction of travel since the new Government came in. I do not want to wade into a Cambridge argument. As a mere Oxford man, I always found my economics professors rather more cheery in their outlook, but perhaps...
I am very grateful to my noble friend; his analysis is absolutely right.
I am very grateful to my noble friend; his analysis is absolutely right.
My Lords, I welcome the establishment of the Office for Budget Responsibility and the independent committee. That is a significant step forward and one on which the noble Lord and the Government should be congratulated. However, we can see a contrast between a thoughtful, objective, fact-based analysis from the committee...
My Lords, I welcome the establishment of the Office for Budget Responsibility and the independent committee. That is a significant step forward and one on which the noble Lord and the Government should be congratulated. However, we can see a contrast between a thoughtful, objective, fact-based analysis from the committee...
My Lords, while enjoying the historical intervention of the noble Lord, Lord Soley, does my noble friend recall the remark of the Leader of the House in the wind-up to the Queen's Speech debate of 1951 when he said that all incoming Governments find skeletons in the closet, but his...
My Lords, while enjoying the historical intervention of the noble Lord, Lord Soley, does my noble friend recall the remark of the Leader of the House in the wind-up to the Queen's Speech debate of 1951 when he said that all incoming Governments find skeletons in the closet, but his...
I am grateful to my noble friend for pointing out the huge success of the pharmaceutical and biopharmaceutical industry in this country. That is why it is so welcome to have the news today that GlaxoSmithKline is putting further facilities into this country that will only enhance the position of...
I am grateful to my noble friend for pointing out the huge success of the pharmaceutical and biopharmaceutical industry in this country. That is why it is so welcome to have the news today that GlaxoSmithKline is putting further facilities into this country that will only enhance the position of...
Well, I have now been reminded. I was not quite around at the time, but I am very grateful to my noble friend for reminding us of these important lessons of history.
Well, I have now been reminded. I was not quite around at the time, but I am very grateful to my noble friend for reminding us of these important lessons of history.
Does my noble friend the Minister accept that one of the critical things that it was important for the coalition Government to do was to reassure the financial markets that we had a handle on the whole question of the deficit which we had inherited? That is one of the...
Does my noble friend the Minister accept that one of the critical things that it was important for the coalition Government to do was to reassure the financial markets that we had a handle on the whole question of the deficit which we had inherited? That is one of the...
My Lords, it is always good to have the noble Lord, Lord Myners, present. I do not suppose that his Government ever applied any spin to any numbers. He shakes his head. Oh, well. All our memories are failing. Seriously, the difference this time is that we have a much...
My Lords, it is always good to have the noble Lord, Lord Myners, present. I do not suppose that his Government ever applied any spin to any numbers. He shakes his head. Oh, well. All our memories are failing. Seriously, the difference this time is that we have a much...